MIF

·April 24, 2020·3 min read

Asthma drug in clinical trial to treat severe COVID-19 patients

A new clinical trial is underway to test ibudilast, an asthma drug approved in Japan, for the treatment of severe COVID-19. Ibudilast is a MIF inhibitor. MIF is a gene that regulates immune response and is a driver of inflammation which results in the cytokine storm associated with coronavirus.

Featured Genetics Neurology

·September 18, 2017·5 min read

Markers For Severe Form of Multiple Sclerosis Identified

Researchers from Yale University have discovered tow cytokines that could help explain how some people develop PPMS. They report a simple genetic test could be used to identify those most at risk of developing progressive multiple sclerosis.